ARCHIVES

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

ACS Prostate Cancer Screening Guideline Urges Doctor-Patient Informed Decision

March 5, 2010

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991